pancuronium and Muscular-Atrophy

pancuronium has been researched along with Muscular-Atrophy* in 6 studies

Other Studies

6 other study(ies) available for pancuronium and Muscular-Atrophy

ArticleYear
Pancuronium-induced prolonged neuromuscular blockade.
    Critical care medicine, 1991, Volume: 19, Issue:12

    Topics: Adult; Aged; Clinical Protocols; Diagnosis, Differential; Drug Synergism; Electromyography; Exercise Therapy; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Infusions, Intravenous; Male; Middle Aged; Monitoring, Physiologic; Muscular Atrophy; Neural Conduction; Pancuronium; Paralysis; Physical Therapy Modalities

1991
Hydrocortisone and pancuronium bromide: acute myopathy during status asthmaticus.
    Critical care medicine, 1988, Volume: 16, Issue:7

    Topics: Asthma; Female; Humans; Hydrocortisone; Middle Aged; Muscular Atrophy; Pancuronium; Status Asthmaticus

1988
Disuse atrophy in a ventilated patient with status asthmaticus receiving neuromuscular blockade.
    Critical care medicine, 1987, Volume: 15, Issue:8

    Topics: Adult; Asthma; Female; Humans; Muscular Atrophy; Neuromuscular Junction; Pancuronium; Respiration, Artificial; Respiratory Care Units; Status Asthmaticus; Time Factors

1987
Skeletal muscle growth failure induced in premature newborn infants by prolonged pancuronium treatment.
    The Journal of pediatrics, 1986, Volume: 109, Issue:5

    Topics: Autopsy; Humans; Infant, Newborn; Male; Muscles; Muscular Atrophy; Muscular Diseases; Pancuronium; Respiratory Distress Syndrome, Newborn

1986
Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation.
    Clinical neurology and neurosurgery, 1985, Volume: 87, Issue:1

    This paper reports on 12 patients in a 3-year period (from 1st July 1980 to 1st July 1983) who were treated with artificial ventilation and with the muscle relaxant pancuronium bromide (Pavulon), over a period of 6 days or longer. After discontinuation of this drug these patients developed severe tetraparesis with areflexia, sometimes combined with disturbances of the extraocular and facial muscles and diffuse muscular atrophy, without sensory disturbances. Seven patients recovered completely after 2-5 months, two made an incomplete recovery and three died due to the primary disease. It is suggested that these neuromuscular complications were caused by prolonged high-dosage Pavulon treatment in combination with renal and hepatic disturbances and/or the use of aminoglucosides.

    Topics: Adult; Aged; Electromyography; Humans; Middle Aged; Muscles; Muscular Atrophy; Nerve Fibers, Myelinated; Neuromuscular Diseases; Pancuronium; Respiration, Artificial

1985
Amyotonia congenita.
    Middle East journal of anaesthesiology, 1974, Volume: 4, Issue:2

    Topics: Anesthesia, Intravenous; Child; Child, Preschool; Female; Humans; Male; Muscular Atrophy; Neuromuscular Diseases; Pancuronium; Postoperative Care; Preoperative Care; Succinylcholine

1974